Results 1 to 10 of about 86,432 (312)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort

Journal of the American Heart Association, 2021
Background One third of primary prevention implantable cardioverter‐defibrillator patients receive appropriate therapy, but all remain at risk of defibrillator complications. Information on these complications in contemporary cohorts is limited.
Marit van Barreveld, Tom E Verstraelen, Pascal F H M Van Dessel   +2 more
exaly   +4 more sources

Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.

Journal of the American College of Cardiology, 2023
BACKGROUND The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to avoid complications related to transvenous implantable cardioverter-defibrillator (TV-ICD) leads.
M. Gold, M. El-Chami, Martin C. Burke, G. Upadhyay, M. Niebauer, J. Prutkin, J. Herre, S. Kutalek, J. Dinerman, B.P. Knight, J. Leigh, Lindsay M. Lucas, N. Carter, A. Brisben, Johan D. Aasbo, R. Weiss   +15 more
semanticscholar   +1 more source

Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score.

European Heart Journal, 2021
AIMS The benefit of prophylactic implantable cardioverter-defibrillator (ICD) is not uniform due to differences in the risk of life-threatening ventricular tachycardia (VT)/ventricular fibrillation (VF) and non-arrhythmic mortality.
Arwa Younis, J. Goldberger, V. Kutyifa, W. Zareba, B. Polonsky, H. Klein, M. Aktas, David T. Huang, J. Daubert, M. Estes, D. Cannom, S. McNitt, K. Stein, I. Goldenberg   +13 more
semanticscholar   +1 more source

Sex Differences in the Risk of First and Recurrent Ventricular Tachyarrhythmias Among Patients Receiving an Implantable Cardioverter-Defibrillator for Primary Prevention

JAMA Network Open, 2022
Key Points Question Is the risk of ventricular tachyarrhythmia similar between women and men with an implantable cardioverter-defibrillator for primary prevention?
S. Saxena, I. Goldenberg, S. McNitt, E. Hsich, V. Kutyifa, N. Bragazzi, B. Polonsky, M. Aktas, David T. Huang, S. Rosero, H. Klein, W. Zareba, Arwa Younis   +12 more
semanticscholar   +1 more source

Subcutaneous defibrillator use with unipolar pacemakers: Cautiously possible

Indian Pacing and Electrophysiology Journal, 2023
Implantation of subcutaneous implantable cardioverter-defibrillator in a patient with existing unipolar pacemaker is against manufacturer recommendations. We report the case of a successful subcutaneous implantable cardioverter-defibrillator implantation
Matanyahu Rubinstein, Angela Zhu, Justin A. Mariani, Hitesh C. Patel   +3 more
doaj   +1 more source

Implantable cardioverter defibrillators [PDF]

Clinical Medicine, 2007
Sudden cardiac death occurs in 70,000-100,000 people annually in the UK, mostly in people with pre-existing heart disease but in 20% it is the first presentation Previous myocardial infarction (Ml) and significant left ventricular dysfunction are associated with a high rate of sudden cardiac death Implantable defibrillators are recommended in the ...
Stuart, Harris, Mehul, Dhinoja
openaire   +2 more sources

Fear of exercise and health-related quality of life in patients with an implantable cardioverter defibrillator [PDF]

, 2003
Several studies have reported improved survival rates thanks to the use of an implantable cardioverter defibrillator (ICD) in the treatment of patients with life-threatening arrhythmia.
Brugemann, J., Coster, J., de Greef, M., van der Schans, C., van Gelder, I., van Ittersum, M.   +5 more
core   +6 more sources

Surface mapping demonstrates compatibility of implantable loop monitor with a continuous‐flow left ventricular assist device

ESC Heart Failure, 2021
Syncope in patients with continuous‐flow left ventricular assist device may be associated with arrhythmia and difficult to determine without an implantable cardioverter defibrillator.
Angela Li, Gourg Atteya, Sirish Vullaganti, Ramanak Mitra   +3 more
doaj   +1 more source

Implantable cardioverter defibrillator as a treatment for massive left ventricular fibroma-induced ventricular arrhythmia in a child [PDF]

Acute and Critical Care, 2021
Pediatric cardiac tumors are rare. Among these, cardiac fibroma is the second most common. Its clinical manifestations depend on size and location of the tumor and include arrhythmia or obstruction to blood flow.
In Su Choi, Hyung Ki Jeong, Hyung Wook Park, Yi-Seul Kim   +3 more
doaj   +1 more source

Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator. [PDF]

PLoS ONE, 2018
Patients with cardiac sarcoidosis are at increased risk of ventricular tachycardia/fibrillation.We tested the hypothesis that the wearable cardioverter defibrillator can be used to mitigate the risk of sudden cardiac death among cardiac sarcoidosis ...
Dirk Skowasch, Steven Ringquist, Georg Nickenig, René Andrié   +3 more
doaj   +1 more source